A Multicenter, Phase 1, Open-label, Dose-Escalation and Expansion Study of TNB-383B, a Bispecific Antibody Targeting BCMA in Subjects with Relapsed or Refractory Multiple Myeloma
- Ganguly, Siddhartha (PI)
- Pingali, S. Ravi (Key Personnel)
- Shah, Shilpan (Key Personnel)
Project: Clinical Trial